video corpo

LA25

LA25

LA25

Product catalog summary
Introduction
The document discusses the therapeutic leukocyte apheresis system developed by MEDICA S.p.A., designed for treating autoimmune diseases such as Ulcerative Colitis, Crohn's Disease, and Rheumatic Arthritis. The system is noted for its effective and selective removal of leukocytes and platelets.

Key Features
  • Effective and selective removal of leukocytes and platelets.
  • High biocompatibility due to the hydrophilic MediSulfone membrane.
  • Sterilization by beta radiation, ensuring no gas residuals.
  • Low total priming volume of 120 ml.
  • Ready-to-use complete kit.
  • Recommended protocol: one session per week for five weeks.

Technical Specifications
  • Fiber material: Polysulfone MediSulfone®.
  • Fiber length: 1-15 mm.
  • Fiber surface: 2 m².
  • Fiber quantity: 25 gr.
  • Blood connectors: Twist lock.
  • Filter length: 180 mm.
  • Treatment blood flow: 30 ml/min.
  • Treatment duration: 60 minutes.
  • Sterilization: Beta rays.
  • Cartridges and blood port material: PC.

Operational Details
  • Blood pump flow rate: 5 to 150 ml/min.
  • Heparin pump flow rate: 0.5 to 15 ml/min.
  • Pressure channels: arterial, venous, prefilter.
  • Display: 4.7” back-lighted color graph.
  • Size: 37x29x36h cm.
  • Weight: 12 kg.

Performance Data
The document includes a schematic drawing of extracorporeal circulation and blood parameters during each apheresis session, showing the means of 10 patients. The data indicates changes in leukocytes, neutrophils, lymphocytes, monocytes, and platelets across five treatment sessions.

Contact Information
Manufactured by MEDICA S.p.A., located in Modena, Italy. Distributed by Menfis Division, Bologna, Italy.
See more

Catalog excerpts

LA25-1

Leukocyte Apheresis for Autoimmune Diseases such us Ulcerative Colitis,Crohn Disease, Rheumatic Arthritis and others THE COLUMN FOR THERAPEUTIC LEUKOCYTE APHERESIS DEVELOPED BY MEDICA SPA, WITH CUTTING-EDGE FEATURES: • EFFECTIVE AND SELECTIVE REMOVAL OF LEUKOCYTES AND PLATELETS; • EXCELLENT BIOCOMPATIBILITY THANKS TO ITS HIGHLY HYDROPHILIC MediSulfone® MEMBRANE; • STERILIZATION BY BETA RADIATION; NO GAS RESIDUAL; • VERY LOW TOTAL PRIMING VOLUME: 120 ML; PROTOCOL: ONE SESSION PER WEEK FOR FIVE WEEKS

 Open the catalog to page 1
LA25-2

LEUKOCYTE ADSORBER LA25 Blood parameters during each apheresis session (means of 10 patients; samples from leukocyte adsorber outflow) Blood parameters during each apheresis session (means of 10 patients; samples from leukocyte adsorber outflow) Baseline Baseline Treatment 1 2 3 Treatment 4 4 Treatment Treatment 5 5 Treatment Treatment 2 Treatment Treatment 3 Treatment Leukocytes Leukocytes Neutrophils Lymphocytes Monocytes Neutrophils Lymphocytes Monocytes Platelets Platelets SCHEMATIC DRAWING OF EXTRACORPOREAL CIRCULATION CLAMP ACCESS VENOUS CHAMBER BLOOD PUMP ARTERIAL CHAMBER Blood pump flow...

 Open the catalog to page 2

All MEDICA catalogs and technical brochures

  1. Vetsmart

    2  Pages

  2. INTENSA®

    2  Pages

  3. Flexiper™

    2  Pages

  4. PICO™ SMART

    4  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.